Exin Therapeutics is a startup based in the United States, 1 tracked investor.
Exin Therapeutics is a startup based in the United States. Brouky records 1 investor associated with the company.
Exin Therapeutics uses AI-trained multimodal models and high-throughput in‑house mouse studies to discover therapeutics that modulate neural activity. Its initial programs target epilepsies associated with autism and Parkinson’s disease.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.